The Cancer Sensitizing Agent market is a subset of the Oncology Drugs market, which focuses on drugs that increase the sensitivity of cancer cells to other treatments. These agents are used to enhance the effectiveness of chemotherapy, radiation therapy, and other treatments. They work by targeting specific pathways in cancer cells, making them more vulnerable to the effects of other treatments. Commonly used agents include monoclonal antibodies, small molecule inhibitors, and other targeted therapies. The Cancer Sensitizing Agent market is highly competitive, with many companies developing and marketing these drugs. Some of the major players in the market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
